MARKET

TXMD

TXMD

Therapeuticsmd Inc
NASDAQ
1.850
+0.070
+3.93%
After Hours: 1.780 -0.07 -3.78% 18:56 07/12 EDT
OPEN
1.830
PREV CLOSE
1.780
HIGH
1.870
LOW
1.790
VOLUME
32.52K
TURNOVER
0
52 WEEK HIGH
4.350
52 WEEK LOW
1.430
MARKET CAP
21.34M
P/E (TTM)
-2.6600
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TXMD last week (0701-0705)?
Weekly Report · 6d ago
Weekly Report: what happened at TXMD last week (0624-0628)?
Weekly Report · 07/01 09:25
Weekly Report: what happened at TXMD last week (0617-0621)?
Weekly Report · 06/24 09:27
Weekly Report: what happened at TXMD last week (0610-0614)?
Weekly Report · 06/17 09:25
Weekly Report: what happened at TXMD last week (0603-0607)?
Weekly Report · 06/10 09:25
Weekly Report: what happened at TXMD last week (0527-0531)?
Weekly Report · 06/03 09:26
Nektar, Verastem among healthcare additions in Russell Microcap; Assertio, Sangamo removed
Nektar, Verastem among healthcare additions in Russell Microcap; Assertio, Sangamo removed from the index. 213 companies will be added and 198 deleted from the annual 2024 Russell index reconstitution. Inovio Pharmaceuticals, Nektar, Ocugen among notable additions.
Seeking Alpha · 05/30 20:55
Weekly Report: what happened at TXMD last week (0520-0524)?
Weekly Report · 05/27 09:27
More
About TXMD
TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).

Webull offers TherapeuticsMD Inc stock information, including NASDAQ: TXMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TXMD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TXMD stock methods without spending real money on the virtual paper trading platform.